Depomed is a leading specialty pharmaceutical company committed to putting the Patient First in everything we do; with a focus on enhancing the lives of patients, families, physicians, providers and in payors through commercialization of products in the areas of pain and neurology, and developing drugs in areas of unmet medical needs.
Depomed currently markets three medicines focused on neuropathic pain and migraine through its Neurology and Pain Business and has an emerging Specialty Business focused on orphan drug indications and areas of unmet medical need.
Depomed has a clear THREE PILLAR strategy for growth:
MAINTAIN a strong/profitable NUCYNTA franchise through a commercialization agreement with Collegium, GROW the Neurology and Pain Business and BUILD a new Specialty Business through a recent Cosyntropin transaction. The company’s strategy is to continue to identify, license and develop new products-that offer enhanced therapeutic options to patient populations that may be underserved by existing therapies.
As part of the transformation strategy, Depomed will be relocating its headquarters out of California. Information about location will be shared during the interview process. Depomed is listed on the NASDAQ market under the ticker DEPO.
Depomed is an AA/EEO/Veterans/Disabled employer.
Company Details
- Employees
- 137
- Founded
- -
- Address
- 7999 Gateway Blvd., Suite 300, Newark,ca 94560,united States
- Phone
- 1-510-744-8000
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- depomed.com
- Keywords
- Pain, CNS, Nucynta, Pharmaceutical, Neurology, Neuropathy.
- HQ
- Newark, CA
Depomed, Inc. Questions
Depomed, Inc.'s helpline number is 1-510-744-8000
Depomed, Inc.'s website is depomed.com
Depomed, Inc.'s LinkedIn profile is https://www.linkedin.com/company/depomed-inc
Depomed, Inc. has
137 employees.
View email and phone details for 137
employees at Depomed, Inc..
Depomed, Inc.'s industry is
Pharmaceutical Manufacturing
Depomed, Inc.'s top competitors are
Assertio,
Revolution Medicines,
Protega Pharmaceuticals,
Amarin Corporation,
Orexigen Therapeutics,
Sunovion Pharmaceuticals,
Abbvie,
Bristol Myers Squibb,
Redhill Biopharma Ltd.,
Gilead Sciences.
Depomed, Inc.'s categories are Pharmaceutical Manufacturing
Depomed, Inc.'s founding year is 1995
